Диссертация (Способы коррекции ранних механизмов канцерогенеза в органах репродуктивной системы), страница 35
Описание файла
Файл "Диссертация" внутри архива находится в папке "Способы коррекции ранних механизмов канцерогенеза в органах репродуктивной системы". PDF-файл из архива "Способы коррекции ранних механизмов канцерогенеза в органах репродуктивной системы", который расположен в категории "". Всё это находится в предмете "медицина" из Аспирантура и докторантура, которые можно найти в файловом архиве РУДН. Не смотря на прямую связь этого архива с РУДН, его также можно найти и в других разделах. , а ещё этот архив представляет собой докторскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени доктора медицинских наук.
Просмотр PDF-файла онлайн
Текст 35 страницы из PDF
Transl Oncol 2011; 4(3):147-56.212279.St-Germain ME, Gagnon V, Asselin E. Regulation of COX-2protein expression by Akt in endometrial cancer cells is mediatedthrough NF-kappaB/IkappaB pathway. Mol Cancer 2004; 3:7.280.Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M,McAdams M, Timmerman MM, Brody LC, Tucker MA. The risk ofcancer associated with specific mutations of BRCA1 and BRCA2 amongAshkenazi Jews.
N Engl J Med 1997; 336:1401–1408.281.Sun H, Enomoto T, Shroyer KR, Ozaki K, Fujita M, Ueda Y,Nakashima R, Kuragaki C, Ueda G, Murata Y. Clonal analysis andmutations in the PTEN and the K-ras genes in endometrial hyperplasia.Diagn Mol Pathol. 2002; 11(4):204-11.282.Sun L, Zhao H, Xu Z, Liu Q, Liang Y, Wang L, Cai X, Zhang L,Hu L, Wang G, Zha X: Phosphatidylinositol 3-kinase/protein kinase Bpathway stabilizes DNA methyltransferase I protein and maintains DNAmethylation.
Cell Signal 2007, 19:2255-2263.283.Sun Q., Zheng Y., Zhang X., Hu X., Wang Y., Zhang S., Zhang D.,Nie H. Novel immunoregulatory properties of EGCG on reducinginflammation in EAE. Frontiers in Bioscience, Landmark, 18, 332-342,2013.284.Szalmas A, Konya J. Epigenetic alterations in cervicalcarcinogenesis. Semin Cancer Biol. 2009; 19:144–52.285.Takayama H, Shin M, Nonomura N, Okuyama A, Aozasa K. p53mutations in prostatic intraepithelial neoplasia and concurrentcarcinoma: analysis of laser capture microdissected specimens from nontransition and transition zones. Jpn J Cancer Res.
2000; 91(9):941-7.286.Tang C., Ang B., Pervaiz S. Cancer stem cell: target for anti-cancertherapy // FASEB J. – 2007; 21 (14): 3777–85.287.Tavares-Murta B.M., de Resende A.D., Cunha F.Q., Murta E.F.Local profile of cytokines and nitric oxide in patients with bacterial213vaginosis and cervical intraepithelial neoplasia. Eur J Obstet GynecolReprod Biol.
2008; 138(1):93-9.288.Terry P., Wolk A., Persson I., et al. Brassica vegetables and breastcancer risk. JAMA 2001; 285(23):2975-2977.289.Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in humangynecological cancer. Cancer Research. 1994; 54(5):1352–1354.290.Toraño E.G., Fernandez A.F., Urdinguio R.G., Fraga M.F. Role ofEpigenetics in Neural Differentiation: Implications for Health andDisease. In Molecular Mechanisms and Physiology of Disease; Springer:New York, NY, USA, 2014.291.Torrisi R., Zanardi S., Pensa F., Valenti G., De Franchis V., NicoloG., Barreca A., Minuto F., Boccardo F.
Epidermal growth factor contentof breast cyst fluids from women with breast cancer or proliferativedisease of the breast. Breast Cancer Res Treat. 1995; 33(3):219-24.292.Trottier H., Franco E.L. The epidemiology of genital humanpapillomavirus infection. Vaccine. 2006; 24(Suppl 1):S1–S15.293.Tsujimoto Y., Takayama H., Nonomura N., at al. PostatrophichyperplasiaoftheprostateinJapan:histologicandimmunohistochemical features and p53 gene mutation analysis.
Prostate2002; 52 (4):279-87.294.Tsukamoto S., Hirotsu K., Kumazoe M., Goto Y., Sugihara K.,Suda T., Tsurudome Y., Suzuki T., Yamashita S., Kim Y., Huang Y.,Yamada K., Tachibana H. Green tea polyphenol EGCG induces lipidraft clustering and apoptotic cell death by activating protein kinase Cδand acid sphingomyelinase through a 67 kDa laminin receptor inmultiple myeloma cells. Biochem J. 2012; 443(2):525-34.295.Tu S.H., Ku C.Y., Ho C.T., Chen C.S., Huang C.S., Lee C.H., et al.Tea polyphenol (-)-epigallocatechin- 3-gallate inhibits nicotine- and214estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation inhuman breast cancer cells.
Mol Nutr Food Res 2011; 55(3):455-466.296.Van Lint C., Emiliani S., Verdin E. The expression of a smallfraction of cellular genes is changed in response to histonehyperacetylation. Gene Expr. 1996; 5(4-5):245-53.297.Varma R, Rollason T, Gupta JK, Maher ER. Endometriosis and theneoplastic process. Reproduction 2004; 127: 293–304.298.Vashisht Gopal Y.N., Arora T.S., Van Dyke M.W.
(2006) Tumournecrosis factor-α depletes histone deacetylase 1 protein through IKK2.EMBO Rep., 7, 291-296.299.Vaskivuo TE, Stenback F, Tapanainen JS. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaBin human endometrial hyperplasia and carcinoma. Cancer 2002; 95:1463–1471.300.Veeck J., Esteller M. Breast cancer epigenetics: from DNAmethylation to microRNAs. J Mammary Gland Biol Neoplasia 2010,15(1):5-17.301.Verit FF, Yucel O.
Endometriosis, leiomyoma and adenomyosis: therisk of gynecologic malignancy. Asian Pac J Cancer Prev. 2013;14(10):5589-97.302.Vermeulen K., Van Bockstaele D. R.; Berneman Z. N. The cellcycle: a review of regulation, deregulation and therapeutic targets incancer. Cell Proliferation 2003; 36 (3): 131–149.303.Villa L.L., Denny L. Methods for detection of HPV infection andits clinical utility. International Journal of Gynecology and Obstetrics.2006; 94: 71-80.304.Virani S, Colacino JA, Kim JH, Rozek LS. Cancer epigenetics: abrief review. ILAR J. 2012; 53(3-4):359-69.215305.Vivar O.I., Lin C.L., Firestone G.L., Bjeldanes L.F. ChinnakannuK., Chen D., Li Y.
et al. 3'-Diindolylmethane induces a G(1) arrest inhuman prostate cancer cells irrespective of androgen receptor and p53status. Biochem Pharmacol. 2009; 78(5):469-76.306.Vivar O.I., Saunier E.F., Leitman D.C., Firestone G.L., BjeldanesL.F. Selective activation of estrogen receptor-beta target genes by 3,3'diindolylmethane. Endocrinology. 2010; 151(4):1662-7.307.Wacholder S, Hartge P, Prentice R, et al. Performance of commongenetic variants in breast-cancer risk models. N Engl J Med. 2010;362(11):986–993.308.Weichert W., Roske A., Gekeler V. et al. (2008) Association ofpatterns of class I histone deacetylase expression with patient prognosisin gastric cancer: a retrospective analysis.
Lancet Oncol., 9, 139-148.309.Weichert W., Roske A., Gekeler V. et al. (2008) Histonedeacetylases 1, 2 and 3 are highly expressed in prostate cancer andHDAC2 expression is associated with shorter PSA relapse time afterradical prostatectomy. Br.
J. Cancer, 98, 604-610.310.Weichert W., Roske A., Niesporek S. et al. (2008) Class I histonedeacetylase expression has independent prognostic impact in humancolorectal cancer: specific role of class I histone deacetylases in vitro andin vivo. Clin. Cancer Res., 14, 1669-1677.311.Weigle W.O., Cochrane G., Dixon F.L.
Clinical aspects ofimmunology.// J. Immune. 1960. - V. 95. - P. 5.312.Weng J.R., Bai L.Y., Chiu C.F., Wang Y.C., Tsai M.H. The dietaryphytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosisin oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, andp53 signaling. Chem Biol Interact. 2012; 195(3):224-230.216313.Widschwendter M, Jiang G, Woods C, Müller HM, Fiegl H, GoebelG, et al.
DNA hypomethylation and ovarian cancer biology. Cancer Res.2004;64:4472–4480.314.Wilbert D.M., Griffin J.E., Wilson J.D. Characterization of thecytosol androgen receptor of the human prostate. J Clin EndocrinolMetab. 1983; 56:113–120.315.Wooster R., Bignell G., Lancaster J. et al (1995) Identification ofthe breast cancer susceptibility gene BRCA2.
Nature, 378, 789–792.316.Worsham M.J., Abrams J., Raju U., Kapke A., Lu M., Cheng J.,Mott D., Wolman S.R. Breast cancer incidence in a cohort of womenwith benign breast disease from a multiethnic, primary health carepopulation. Breast J 2007; 13:115–121.317.Wren J.D., Wu Y., Guo S.W. A system-wide analysis ofdifferentially expressed genes in ectopic and eutopic endometrium.
HumReprod, 2007. 22(8): p. 2093-102.318.Yang G.F., Deng C.S., Xiong Y.Y., Gong L.L., Wang B.C., Luo J.Expression of nuclear factor-kappa B and target genes in gastricprecancerouslesionsandadenocarcinoma:associationwithHelicobactor pylori cagA (+) infection. World J Gastroenterol. 2004;10(4):491-6.319.Yang X, Phillips DL, Ferguson AT et al. Synergistic activation offunctional estrogen receptor (ER)-alpha by DNA methyltransferase andhistone deacetylase inhibition in human ER-alpha-negative breast cancercells.
Cancer Res 2001; 61:7025–7029.320.Yavuz E., et al., Genistein causes regression of endometrioticimplants in the rat model. Fertil Steril, 2007; 88(4 Suppl): p. 1129-34.321.Yin H., Chu A., Li W., Wang B., Shelton F., Otero F., Nguyen D.G.,Caldwell J.S., Chen Y.A. Lipid G protein-coupled receptor ligand217identification using beta-arrestin PathHunter assay. J Biol Chem. 2009;284(18):12328-38.322.Yin X.F., Chen J., Mao W., Wang Y.H., Chen M.H. A selective arylhydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastriccancer cell growth. J Exp Clin Cancer Res. 2012; 31:46.323.Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al.
let-7 regulatesself renewal and tumorigenicity of breast cancer cells. Cell 2007;131:1109–1123.324.Zeleniuch-Jacquotte A., Shore R.E., Afanasyeva Y., Lukanova A.,et al. Postmenopausal circulating levels of 2- and 16α-hydroxyestroneand risk of endometrial cancer. British Journal of Cancer (2011) 105,1458–1464.325.Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, Sun J, Yu Y, ZhouW, Zheng Q, Wu M, Otterson GA, Zhu WG.
Acetylation of p53 at lysine373/382 by the histone deacetylase inhibitor depsipeptide inducesexpression of p21(Waf1/Cip1). Mol.Cell Biol. 2006; 26: 2782-90.326.Zupi E., Sbracia M., Marconi D., Alò P., Atzei G., Brazolin T.,Arduini D., Romanini C. TNFalpha expression in hyperplasticendometrium. Am J Reprod Immunol. 2000; 44(3):153-9.327.Zynger D.
L., Yang X. High-grade Prostatic IntraepithelialNeoplasia of the Prostate: The Precursor Lesion of Prostate Cancer. IntJ Clin Exp Pathol. 2009; 2(4): 327–338.218.